Rare Disease Patient Advocacy and Medical Affairs: Why They Come First
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th…
Reverse Mentoring with Up-and-Coming Talent
In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an…
How to Write the Biopharma S-1 Business Section
Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1…
Spotlight on Transitions
This topic of “transition” came home to me (literally and figuratively) over the Thanksgiving holiday. With our adult…
Networking in Biopharma: Four Ways to Build Better Relationships
Networking! You know, that activity that one either embraces or goes running away from as quickly as possible. For…
Biopharma Brand Team and Launch Team Structure: A Practical Guide
For those of you following closely (thank you!), you may recall that in an earlier e-conversation — 21st Century…
Biopharma Governance and Decision-Making: How to Fix What’s Broken
At your next company lunch and learn, try this experiment: Ask ten people from different functions to take a blank…